An entire population of adults has not been accounted for when it comes to administering COVID-19 vaccinations. Pregnant women, who are at higher risk of severe illness if they contract the virus, were excluded from vaccine clinical trials, and now there is debate and concern about whether or not they are safe for expecting mothers.
March of Dimes CEO Stacey Stewart said the exclusion of pregnant women in vaccine testing is an outdated process and a roadblock for the advancement of science.
"It's 2021, we need to take a more modern approach to how we advance science, especially as it relates to pregnant women [and] to newborn babies," Stewart told Cheddar. "At the March of Dimes, we've been a long advocate for newborn screening for all the things that would help us to make sure that moms and babies are protected,"
While the CDC and the World Health Organization both agree that patients should consult with a doctor to make the best decision for themselves and their baby, the impact of the vaccines, particularly the Moderna and Pfizer/BioNTech mRNA vaccines that do not use the live version of the virus, on pregnancies is unknown. So far, both companies are monitoring women who became pregnant after getting vaccinated.
According to Stewart, the fact that the Moderna and Pfizer's vaccines do not "influence or alter the DNA" signals that they would be a safe option for pregnant women to consider.
"What we are saying at the March of Dimes is consult your health care practitioner," she said. "But by all means, know that as a pregnant woman you are at potentially higher risk of severe illness if you contract COVID-19, so we would certainly recommend that women give serious thought to receiving the vaccine when they're able to."
Last week, NIAID Director Dr. Anthony Fauci said of the more than 10,000 pregnant women that have been vaccinated, no major incidents have been reported, which Stewart said is a good indicator of safety.
"If a woman is at high risk, is an essential worker, is at high risk of being in contact with someone that has COVID-19, is at high risk herself of severe illness because of comorbidities, please consider the vaccine because it could save your life. It could save the life of your baby as well," she noted.
An FDA panel has recommended the low-dose Pfizer vaccine for kids ages five to 11. The recommendation now cues up the FDA to authorize the vaccine. Next week, the CDC will consider its own authorization. Once signed off by the CDC, the Pfizer vaccine can be administered in children immediately. Dr. Christina Johns, Senior Medical Advisor at PM Pediatrics, joined Cheddar's Search for a Cure.
Dr. Vivek Cherin, Internal Medicine Physician at Amita Health, joined Cheddar's Search for a Cure to break down what we need to know about eligibility and availability of COVID-19 vaccine boosters.
World leaders will converge this weekend at the 2021 G20 Summit in Rome and the UN COP26 conference in Glasgow with the climate crisis on the agenda. Lord Adair Turner, chair of the Energy Transitions Commission, joined Cheddar to discuss what people can expect to come out of the climate-focused conferences. Turner also noted that one of the biggest hurdles for the attending nations will be coming to a uniform decision on expanding on the Paris Climate Accord goals that have become insufficient to prevent global warming by 1.5 degrees celsius.
Nicole Lambert, President at Myriad Genetics joins ChedHER to discuss how to expand access to genetic testing for all women, and how her experience as a 'pre-vivor' motivates her role in the industry.
Carlo and Baker cover Facebook's big rebrand, the latest on Biden's economic agenda and more. Plus, ranking the best Halloween candy and the worst couple's costumes.
Proptech startup Juno recently raised $20 million in a Series A funding round. The company says the funds will be used to further its mission of building sustainable and affordable apartment buildings across the United States. Juno Co-Founder and CEO Jonathan Sherr joined Cheddar News' Closing Bell to discuss.
Stacey Stevens, President of iCAD, joins 'Cheddar Innovates' to discuss how 'Profound A.I. Risk' works as a short-term breast cancer risk estimation for women.
On this episode of 'Cheddar Innovates': President of iCAD breaks down how its technology is being used as a short-term breast cancer risk estimation for women; A look at Curiosity Stream's 'The Science of Thrills.'
Pharmaceutical company Merck has announced that it will share the formula of its COVID-19 pill with poor countries free of charge. The company still intends to charge wealthier nations leaving the end cost at more than $700 per five-day treatment course.
Dems race for a deal on President Biden's economic agenda ahead of his big foreign trip. What to make of the latest threat assessment in Afghanistan. Plus, the meme cryptocurrency of the moment that's now worth more than many Fortune 500 companies.
